A novel DYRK1B inhibitor AZ191 demonstrates that DYRK1B acts independently of GSK3β to phosphorylate cyclin D1 at Thr(286), not Thr(288).
about
Selectivity Profiling and Biological Activity of Novel β-Carbolines as Potent and Selective DYRK1 Kinase InhibitorsThe Down syndrome-related protein kinase DYRK1A phosphorylates p27(Kip1) and Cyclin D1 and induces cell cycle exit and neuronal differentiationRole of non-genomic androgen signalling in suppressing proliferation of fibroblasts and fibrosarcoma cellsBafilomycin A1 induces caspase-independent cell death in hepatocellular carcinoma cells via targeting of autophagy and MAPK pathways.Metformin induces degradation of cyclin D1 via AMPK/GSK3β axis in ovarian cancer.DYRK1A-mediated Cyclin D1 Degradation in Neural Stem Cells Contributes to the Neurogenic Cortical Defects in Down Syndrome.Identification of DYRK1B as a substrate of ERK1/2 and characterisation of the kinase activity of DYRK1B mutants from cancer and metabolic syndrome.DYRK1B blocks canonical and promotes non-canonical Hedgehog signaling through activation of the mTOR/AKT pathway.Live imaging of transforming growth factor-β activated kinase 1 activation in Lewis lung carcinoma 3LL cells implanted into syngeneic mice and treated with polyinosinic:polycytidylic acid.A wake-up call to quiescent cancer cells - potential use of DYRK1B inhibitors in cancer therapy.Targeting DYRK1B suppresses the proliferation and migration of liposarcoma cells.MuvB: A Key to Cell Cycle Control in Ovarian Cancer.
P2860
Q28546672-012A181A-AB69-455E-82CB-EC325F2A097CQ33952905-458FCDAF-C575-454D-98FD-9D59B6D1F91AQ36291960-8F29BEAA-5B05-454A-9100-BBE2555B2902Q37414050-B0AE640C-B9B5-418D-B4B1-F1578019B129Q38774498-D2E98527-DEA5-4C1F-AC6E-972E20E56487Q40773653-AFC15B0B-E6BA-4301-B62C-15CE7B264989Q41782221-7DF5D66C-8573-4C7A-9E35-7A2ACB1F001DQ42316192-D467AB8B-0107-436C-8597-9A10D3885AC7Q42385640-D4AC4DD3-198E-4D47-9856-30DEE5DE0006Q46250363-8BA8A57E-3A9F-47B6-BE94-FC915673F011Q52641599-2E3D709D-BB69-466F-8844-0D1659C357CCQ55286778-53535C79-D8DC-44E1-A44D-784BB6A4068B
P2860
A novel DYRK1B inhibitor AZ191 demonstrates that DYRK1B acts independently of GSK3β to phosphorylate cyclin D1 at Thr(286), not Thr(288).
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
A novel DYRK1B inhibitor AZ191 ...... D1 at Thr(286), not Thr(288).
@en
A novel DYRK1B inhibitor AZ191 ...... D1 at Thr(286), not Thr(288).
@nl
type
label
A novel DYRK1B inhibitor AZ191 ...... D1 at Thr(286), not Thr(288).
@en
A novel DYRK1B inhibitor AZ191 ...... D1 at Thr(286), not Thr(288).
@nl
prefLabel
A novel DYRK1B inhibitor AZ191 ...... D1 at Thr(286), not Thr(288).
@en
A novel DYRK1B inhibitor AZ191 ...... D1 at Thr(286), not Thr(288).
@nl
P2093
P2860
P356
P1433
P1476
A novel DYRK1B inhibitor AZ191 ...... n D1 at Thr(286), not Thr(288)
@en
P2093
Anne L Ashford
David Oxley
Jason Kettle
Kevin Hudson
Pamela A Lochhead
Sylvie Guichard
P2860
P356
10.1042/BJ20130461
P407
P50
P577
2014-01-01T00:00:00Z